Jean-Marc Lapierre

This inventor holds 34 USPTO granted patents and 10 published patent applications, plus 5 CIPO patents and 8 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Arqule, Inc., Hoffmann-La Roche Inc., Syntex (u.s.a.) Inc.. Active years: 2002-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Marc Lapierre. Retrieved from https://idiyas.com/inventor/jean-marc-lapierre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 (Patent Applications = 10)

% Patents Active = 64.7

CIPO Patents = 5 (Patent Applications = 7)

EPO Patents = 8 (Patent Applications = 13)

Average Co-Inventor Count = 4.7

ph-index = 8

Forward Citations = 172(Granted Patents)

Location History:

Mountain View, CA (US) (2002 - 2004)
Pelham, NH (US) (2004 - 2024)

Company Filing History:

Hoffmann-La Roche Inc.

Cyteir Therapeutics, Inc.

Years Active: 2002-2024

Loading Chart...

Areas of Expertise:

RAD51 Inhibitors

Amino-Pyrrolopyrimidinone

Retinoid Agonists

Tumor Targeting

Quinone Prodrugs

Imidazopyridinyl Compounds

Heterocyclic Compounds

Pharmaceutical Compositions

Proliferation Disorders

Synthesis Methods

Thiophene Derivatives

Benzo Compounds

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11932636 - RAD51 inhibitors (2024-03-19),

2. 11247988 - RAD51 inhibitors (2022-02-15),

3. 11020400 - Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof (2021-06-01),

4. 11020398 - Amino-pyrrolopyrimidinone compounds and methods of use thereof (2021-06-01),

5. 10933065 - Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof (2021-03-02),

6. 10245263 - Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof (2019-04-02),

7. 9949981 - Compositions and methods for treating proliferation disorders (2018-04-24),

8. 9630968 - Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof (2017-04-25),

9. 8962619 - Substituted imidazopyridinyl-aminopyridine compounds (2015-02-24),

10. 8815854 - Substituted imidazopyridinyl compounds (2014-08-26),

11. 8614228 - Quinone prodrug compositions and methods of use (2013-12-24),

12. 8609688 - Substituted imidazopyridinyl-aminopyridine compounds (2013-12-17),

13. 8569331 - Substituted benzo[f]lmidazo[1,2-d]pyrido[2,3-b][1,4]diazepine compounds (2013-10-29),

14. 8541407 - Substituted benzo-pyrido-triazolo-diazepine compounds (2013-09-24),

15. 8501770 - Substituted imidazopyridinyl-aminopyridine compounds (2013-08-06),

Title: The Innovative Mind of Jean-Marc Lapierre

Introduction: Jean-Marc Lapierre, a talented inventor hailing from Pelham, New Hampshire, has made significant contributions to the world of innovations with his creative and forward-thinking approach.

Latest Patents: Jean-Marc Lapierre holds several patents in various fields, showcasing his diverse range of expertise and innovative spirit. His latest patents focus on cutting-edge technologies in the fields of renewable energy and sustainable materials.

Career Highlights: Throughout his illustrious career, Jean-Marc Lapierre has been at the forefront of groundbreaking inventions that have revolutionized industries. His keen eye for detail and passion for innovation have led to the development of products that have had a lasting impact on society.

Collaborations: Jean-Marc Lapierre has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: In conclusion, Jean-Marc Lapierre stands as a shining example of an inventor who has dedicated his life to pushing the boundaries of what is possible through innovation. His relentless pursuit of excellence and commitment to creating a better future make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.